{
  "nctId": "NCT02665273",
  "briefTitle": "Greater Occipital Nerve Block With Bupivacaine for Acute Migraine",
  "officialTitle": "A Randomized, Sham-controlled Trial of Greater Occipital Nerve Block as Second Line Therapy for ED Patients With Acute Migraine",
  "protocolDocument": {
    "nctId": "NCT02665273",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2015-06-01",
    "uploadDate": "2020-07-28T11:01",
    "size": 259206,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02665273/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE3"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 28,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-07-01",
    "completionDate": "2018-01",
    "primaryCompletionDate": "2018-01",
    "firstSubmitDate": "2016-01-15",
    "firstPostDate": "2016-01-27"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* ED patient with acute migraine or probable migraine\n* Fail first line therapy with metoclopramide\n\nExclusion Criteria:\n\n* Can't obtain consent\n* Concern for secondary headache\n* Skull defect\n* Propensity for bleeding\n* Overlying infection\n* Pregnancy\n* Allergy, intolerance study medication",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of Participants Who Achieve Freedom From Headache",
        "description": "Pain assessed using a standard ordinal headache intensity scale, in which subjects describe their headache as \"severe\", \"moderate\", \"mild\", or \"none\". Those with headache level = none, experience freedom from headache.",
        "timeFrame": "30 minutes"
      }
    ],
    "secondary": [
      {
        "measure": "Sustained Headache Relief",
        "description": "Attaining a headache level of \"mild\" or \"none\" within one hour of procedure and maintaining this for 48 hours without use of additional medication",
        "timeFrame": "48 hours"
      },
      {
        "measure": "Would Want the Same Treatment Again During a Subsequent Migraine",
        "description": "Participants will be asked the following question: Do you want to receive the same procedure the next time you come to the ER with migraine?",
        "timeFrame": "48 hours"
      }
    ],
    "other": [
      {
        "measure": "Change in Pain Score Assessed by Verbal Pain Scale (0-10)",
        "description": "The numerical scale, 0-10 pain scores will be obtained with 0 being \"no pain\" and 10 being \"the worst pain imaginable.\"",
        "timeFrame": "60 minutes"
      }
    ]
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 1,
      "totalCount": 4
    },
    "studyDesign": {
      "phases": [
        "PHASE3"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 51,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:52.589Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}